Cable Hill Partners, LLC Sarepta Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$112.21 - $151.95 $3,254 - $4,406	-29 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $2,882 - $4,037	-25 Reduced 46.3%	29 $4,000
Q2 2018 Aug 03, 2018	SELL	$71.74 - $153.69 $1,291 - $2,766	-18 Reduced 25.0%	54 $7,000
Q1 2018 Apr 20, 2018	SELL	$54.02 - $82.27 $6,536 - $9,954	-121 Reduced 62.69%	72 $5,000
Q3 2017 Oct 27, 2017	BUY	$35.73 - $47.15 $3,108 - $4,102	87 Added 82.08%	193 $9,000
Q2 2017 Aug 14, 2017	BUY	N/A	106	106 $4,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.